Alexandria Real Estate Equities-backed Applied Therapeutics has gone public despite having to drastically cut its expectations for the offering.

Illumina Ventures and M Ventures made follow-on investments in synthetic DNA platform developer DNA Script as part of its $38.5m series B round.

Mahindra's private equity unit invested $29.3m in the ophthalmology centre operator, in a deal that enabled Matrix Partners India to exit.

UPMC-founded ID Connect offers a telemedicine platform to help hospitals manage the spread of serious infectious diseases.

Meditation device manufacturer Core has attracted $4m from seed investors including Stanford-StartX Fund as it ramps up towards the full release of its product.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Clalit Health Services unit Mor Research Applications has backed Aspire Venture Precision Medicine Fund and partnered its Smart Health Innovation Lab.

ICL medical device developer GripAble has added funding from Triple Point Impact EIS Investment Fund to $198,000 of equity secured from investors including Oxford Technology Management in 2017.

DNA sequencing spinout Longas Technologies has been working away from public view since 2015, having secured cash from the Medical Research Commercialisation Fund as well as its own founding team and directors.

Optum Ventures co-led a round for Icometrix, the developer of a diagnostics system for neurological disorders, with Forestay Capital and Capricorn Venture Partners.